Analysts expect Neogenomics Inc to report revenue of 198.35 M for Q4 26, against a range of 183.28 M to 213.42 M. The most recent reported quarter, Q3 26, came in at 209.25 M, a 2.9% miss against the 215.50 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 172.00 M | 168.03 M | 181.33 M | 187.80 M | 190.17 M | 186.67 M | 201.66 M | 209.25 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 177.85 M | 181.16 M | 182.66 M | 203.23 M | 195.09 M | 183.55 M | 218.40 M | 232.74 M | 213.42 M | 207.00 M | 214.30 M | 239.59 M | 260.75 M | 249.18 M | 272.68 M | 246.93 M | |||||||||
| Low Estimate | 155.97 M | 153.09 M | 158.90 M | 183.94 M | 167.98 M | 161.37 M | 196.14 M | 198.26 M | 183.28 M | 180.97 M | 197.22 M | 207.68 M | 217.77 M | 221.61 M | 226.30 M | 227.56 M | |||||||||
| Consensus Estimate | 166.91 M | 167.12 M | 170.78 M | 193.58 M | 181.53 M | 172.46 M | 207.27 M | 215.50 M | 198.35 M | 193.99 M | 205.76 M | 223.63 M | 239.26 M | 235.39 M | 249.49 M | 237.25 M |
Analysts expect Neogenomics Inc to report earnings per share of 0.07 for Q4 26, against a range of 0.07 to 0.07. The most recent reported quarter, Q3 26, came in at 0.07, a 16.7% beat against the 0.06 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.04 | 0.00 | 0.03 | 0.03 | 0.06 | 0.01 | 0.05 | 0.07 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 0.03 | -0.01 | 0.02 | 0.02 | 0.04 | 0.01 | 0.03 | 0.07 | 0.07 | 0.05 | 0.09 | 0.09 | 0.11 | 0.08 | 0.10 | 0.12 | |||||||||
| Low Estimate | 0.03 | -0.01 | 0.02 | 0.02 | 0.04 | 0.01 | 0.03 | 0.05 | 0.07 | 0.05 | 0.07 | 0.09 | 0.09 | 0.06 | 0.10 | 0.10 | |||||||||
| Consensus Estimate | 0.03 | -0.01 | 0.02 | 0.02 | 0.04 | 0.01 | 0.03 | 0.06 | 0.07 | 0.05 | 0.08 | 0.09 | 0.10 | 0.07 | 0.10 | 0.11 |
Pull Wall Street consensus for Neogenomics Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=NEO&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "NEO", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=NEO&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();